These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 34982304)
21. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160 [TBL] [Abstract][Full Text] [Related]
22. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287 [TBL] [Abstract][Full Text] [Related]
23. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. Subauste CS; Wessendarp M; Sorensen RU; Leiva LE J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287 [TBL] [Abstract][Full Text] [Related]
24. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype. Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518 [TBL] [Abstract][Full Text] [Related]
25. Respiratory Complications in Patients with Hyper IgM Syndrome. Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658 [TBL] [Abstract][Full Text] [Related]
33. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases. Zelazko M; Carneiro-Sampaio M; Cornejo de Luigi M; Garcia de Olarte D; Porras Madrigal O; Berrón Perez R; Cabello A; Rostan MV; Sorensen RU J Clin Immunol; 1998 Mar; 18(2):161-6. PubMed ID: 9533660 [TBL] [Abstract][Full Text] [Related]
34. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients. Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377 [TBL] [Abstract][Full Text] [Related]
36. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome. Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731 [TBL] [Abstract][Full Text] [Related]
37. Primary immunodeficiency diseases in Latin America: proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board. Leiva LE; Bezrodnik L; Oleastro M; Condino-Neto A; Costa-Carvalho BT; Grumach AS; Espinosa-Rosales FJ; Franco JL; King A; Inostroza J; Quezada A; Porras O; Sorensen RU Allergol Immunopathol (Madr); 2011; 39(2):106-10. PubMed ID: 21345576 [TBL] [Abstract][Full Text] [Related]
38. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America. Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411 [TBL] [Abstract][Full Text] [Related]